Mylan Laboratories Limited Clarithromycin Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Clarithromycin Export Records India — #13 Exporter, 3 Shipments, $150.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Clarithromycin

India Pharmaceutical Trade Intelligence

$98.4M334 Suppliers144 CountriesHS 30042063

ExportsIndia → UNITED KINGDOM18.6%India → BELGIUM11.6%

ImportsUNITED STATES → India$112.9K ROMANIA → India$7.6K

#1 Supplier: MICRO LABS #1 Buyer: BROWN AND

Mylan Laboratories Limited — Clarithromycin Exporter #13 | $150.0K Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Clarithromycin Exporter Profile

Indian Pharmaceutical Exporter · #13 for Clarithromycin · $150.0K export value · DGFT Verified

Mylan Laboratories Limited is the #13 Indian exporter of Clarithromycin with $150.0K in export value and 3 verified shipments. Mylan Laboratories Limited holds a 0.2% market share in Clarithromycin exports across 1 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Clarithromycin Export Profile: Buyers & Destinations

Mylan Laboratories Limited Clarithromycin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Clarithromycin?

Country	Value	Shipments	Share
BELGIUM	$11.4M	241	21.9%
UNITED KINGDOM	$8.6M	171	16.5%
KENYA	$5.8M	137	11.2%
TANZANIA	$4.3M	85

Who Are the Top Buyers of Clarithromycin from India?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$9.2M	186
BROWN AND BURK UK LIMITED	UNITED KINGDOM	$1.6M	32
ASTRA PHARMA (T) LTD	TANZANIA	$900.0K	18
DYVENPRO DISTRIBUCION Y VENTA DE	ECUADOR	$850.0K	17
AUROLOGISTICS LLC, (AUROBINDO PHARM	UNITED STATES	$750.0K	15
AUROLOGISTICS LLC (AUROBINDO PHARMA	UNITED STATES	$550.0K	11
HEKO PHARMACY LTD	TANZANIA	$500.0K	10
RISING PHARMA HOLDINGS INC	UNITED STATES	$300.0K	6
BROWN AND BURK LIMITED	UNITED KINGDOM	$200.0K	4
CIPLA KENYA LTD C/O IMPERIAL MANAGE	KENYA	$100.0K	2

India's Clarithromycin is purchased by 811 buyers worldwide. The top buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by BROWN AND BURK UK LIMITED and ASTRA PHARMA (T) LTD.

How Does Mylan Laboratories Limited Compare to Nearest Clarithromycin Exporters?

Exporters ranked immediately above and below #13 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
8	LINCOLN PHARMACEUTICALS LTD	$850.0K	17	3	$50.0K
15	PROSFORA TECHNOLOGIES PRIVATE LIMITED	$300.0K	6	1	$50.0K
13	MYLAN LABORATORIES LIMITED ★	$150.0K	3	1	$50.0K

Mylan Laboratories Limited ranks #13 among 334 Indian Clarithromycin exporters. Average shipment value of $50.0K compared to the market average of $183.3K. The closest competitors by value are LINCOLN PHARMACEUTICALS LTD and PROSFORA TECHNOLOGIES PRIVATE LIMITED.

Which Indian Ports Ship Clarithromycin Exports?

Port	Shipments	% Share
SAHAR AIR	365	10.2%
DELHI AIR CARGO ACC (INDEL4)	296	8.3%
SAHAR AIR CARGO ACC (INBOM4)	282	7.9%
DELHI AIR	258	7.2%
NHAVA SHEVA SEA (INNSA1)	229	6.4%
JNPT/ NHAVA SHEVA SEA	156	4.4%
JNPT	125	3.5%
DHANNAD ICD	124	3.5%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Clarithromycin Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Clarithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 144+ countries, 811+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Clarithromycin

Clarithromycin

Mylan Laboratories Limited — Clarithromycin Exporter Profile

Mylan Laboratories Limited — Clarithromycin Export Profile: Buyers & Destinations

Where Does India Export Clarithromycin?

Who Are the Top Buyers of Clarithromycin from India?

What Is India's Total Clarithromycin Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Clarithromycin Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Clarithromycin Exporters?

Regulatory Requirements: Exporting Clarithromycin to Key Markets

United Kingdom — MHRA

United States — FDA

How Does Mylan Laboratories Limited Compare to Nearest Clarithromycin Exporters?

Which Indian Ports Ship Clarithromycin Exports?

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Clarithromycin Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Clarithromycin Export Data from Mylan Laboratories Limited

Clarithromycin Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source